"Lung Cancer: Controversies to Consensus" webinar was held virtually on 13.03.2022. Dr. Tanjeel Janjua ( Clinical Oncologist) from UK and Dr. Dodul Mondal (Radiation Oncologist) from Delhi took part in a debate to address whether a non-surgical treatment with concurrent chemo-radiotherapy followed by adjuvant Durvalumab could the standard treatment for resectable stage III NSCLC.
